Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Ordinary Shares, no par value per share
-
Shares outstanding
-
112,245,592
-
Total 13F shares
-
69,182,535
-
Share change
-
+1,899,411
-
Total reported value
-
$5,829,865,247
-
Put/Call ratio
-
97%
-
Price per share
-
$84.27
-
Number of holders
-
256
-
Value change
-
+$164,443,633
-
Number of buys
-
124
-
Number of sells
-
108
Institutional Holders of NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) as of Q4 2019
As of 31 Dec 2019,
NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) was held by
256 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
69,182,535 shares.
The largest 10 holders included
FMR LLC, BAILLIE GIFFORD & CO, VANGUARD GROUP INC, BlackRock Inc., Capital World Investors, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, Capital International Investors, MORGAN STANLEY, and Darsana Capital Partners LP.
This page lists
256
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.